loader
Please Wait
Applying Filters...

Athena Athena

X

List of Inactive Ingredients used to produce Triacetin API listed on PharmaCompass with Finished Dosage Forms (Formulations)

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 CAPSULE (1)

02 CAPSULE, COATED PELLETS (1)

03 CAPSULE, ENTERIC COATED PELLETS (1)

04 CAPSULE, EXTENDED RELEASE (1)

05 CAPSULE, SUSTAINED ACTION (1)

06 CONCENTRATE (1)

07 GEL (1)

08 PATCH (1)

09 PATCH, CONTROLLED RELEASE (1)

10 POWDER, FOR ORAL SUSPENSION (1)

11 SUSPENSION (1)

12 SUSPENSION, EXTENDED RELEASE (1)

13 TABLET (IMMED./COMP. RELEASE), FILM COATED (1)

14 TABLET, CHEWABLE (1)

15 TABLET, COATED (1)

16 TABLET, DELAYED ACTION, ENTERIC COATED (1)

17 TABLET, EXTENDED RELEASE (1)

18 TABLET, FILM COATED (1)

19 TABLET, SUSTAINED ACTION (1)

filter

01 0 (1)

02 0.32 (1)

03 0.72 (1)

04 1 (1)

05 1.02 (1)

06 1.18 (1)

07 1.21 (1)

08 1.36 (1)

09 1.56 (1)

10 1.96 (1)

11 2.76 (1)

12 3.24 (1)

13 5.1 (1)

14 6 (1)

15 12.75 (1)

16 15.12 (1)

17 22.1 (2)

18 50 (1)

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
GEL
ENDOCERVICAL
102761
XHX3C3X673
0
NA
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
CAPSULE
ORAL
102761
XHX3C3X673
3.24
MG
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
CAPSULE, COATED PELLET...
ORAL
102761
XHX3C3X673
1.21
MG
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
CAPSULE, ENTERIC COATE...
ORAL
102761
XHX3C3X673
5.1
MG
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
CAPSULE, EXTENDED RELE...
ORAL
102761
XHX3C3X673
12.75
MG
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
CAPSULE, SUSTAINED ACT...
ORAL
102761
XHX3C3X673
2.76
MG
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
CONCENTRATE
ORAL
102761
XHX3C3X673
50
MG/1ML
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
POWDER, FOR ORAL SUSPE...
ORAL
102761
XHX3C3X673
1.02
MG/5ML
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
SUSPENSION
ORAL
102761
XHX3C3X673
0.32
MG/1ML
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

FDA INACTIVE INGREDIENT DATABASE

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content

TRIACETIN

URL Supplier Web Content
SUSPENSION, EXTENDED R...
ORAL
102761
XHX3C3X673
1.18
MG/5ML
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY